Literature DB >> 1469396

Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

S G Hasselbalch1, G Oberg, S A Sørensen, A R Andersen, G Waldemar, J F Schmidt, K Fenger, O B Paulson.   

Abstract

Regional cerebral blood flow (rCBF) was studied in 18 patients with Huntington's disease (HD) and 19 age- and sex-matched controls with high resolution single photon emission computerised tomography (SPECT), using Tc-99m-HMPAO. Significant reductions in tracer uptake were found in the caudate and lentiform nuclei (20 and 8%) and in the cerebral cortex, especially in the frontal and parietal areas (11-13%). No significant reductions were found in the thalamus, mesial temporal cortex, and occipital cortex. Fourteen patients had neuropsychological testing. Relationship between rCBF and cognitive function was tested by regression analysis. A linear relationship was found between test scores of Wisconsin Card Sorting Test, Picture Arrangement Test and blood flow in the caudate nucleus. Other tests of cognitive function (Block Design Test, Face and Word Recognition Test, Street Fragmented Pictures Test, and Similarities Test) correlated better with flow in the cortical regions believed to be involved in solving those particular tests. These findings indicate, that blood flow is reduced in both cortical and subcortical structures in symptomatic HD, and that both reductions in cortical and subcortical blood flow may be related to cognitive function in HD.

Entities:  

Mesh:

Year:  1992        PMID: 1469396      PMCID: PMC1015285          DOI: 10.1136/jnnp.55.11.1018

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

2.  A single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple cross sections.

Authors:  E M Stokely; E Sveinsdottir; N A Lassen; P Rommer
Journal:  J Comput Assist Tomogr       Date:  1980-04       Impact factor: 1.826

3.  99mTc-d,l-HMPAO and SPECT of the brain in normal aging.

Authors:  G Waldemar; S G Hasselbalch; A R Andersen; F Delecluse; P Petersen; A Johnsen; O B Paulson
Journal:  J Cereb Blood Flow Metab       Date:  1991-05       Impact factor: 6.200

4.  Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.

Authors:  T Kuwert; H W Lange; K J Langen; H Herzog; A Aulich; L E Feinendegen
Journal:  Brain       Date:  1990-10       Impact factor: 13.501

Review 5.  Huntington disease: genetics and epidemiology.

Authors:  P M Conneally
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

6.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

7.  Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum.

Authors:  M F Beal; K J Swartz; S F Finn; E D Bird; J B Martin
Journal:  Brain Res       Date:  1988-06-28       Impact factor: 3.252

8.  Brain atrophy in Huntington's disease. A CT-scan study.

Authors:  S E Starkstein; S E Folstein; J Brandt; G D Pearlson; A McDonnell; M Folstein
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

9.  Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study.

Authors:  K A Bamford; E D Caine; D K Kido; W M Plassche; I Shoulson
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

10.  Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.

Authors:  D E Kuhl; M E Phelps; C H Markham; E J Metter; W H Riege; J Winter
Journal:  Ann Neurol       Date:  1982-11       Impact factor: 10.422

View more
  22 in total

1.  Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

Authors:  J Jean Chen; David H Salat; H Diana Rosas
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

2.  Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.

Authors:  J M G van Bergen; J Hua; P G Unschuld; I A L Lim; C K Jones; R L Margolis; C A Ross; P C M van Zijl; X Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-17       Impact factor: 3.825

Review 3.  Brain imaging and cognitive dysfunctions in Huntington's disease.

Authors:  Alonso Montoya; Bruce H Price; Matthew Menear; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

4.  Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease.

Authors:  Robert C Wolf; Georg Grön; Fabio Sambataro; Nenad Vasic; Nadine D Wolf; Philipp A Thomann; Carsten Saft; G Bernhard Landwehrmeyer; Michael Orth
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

5.  Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.

Authors:  L H Pinborg; C Videbaek; S G Hasselbalch; S A Sørensen; A Wagner; O B Paulson; G M Knudsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

6.  EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease.

Authors:  Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda M Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
Journal:  J Neurol       Date:  2010-12-12       Impact factor: 4.849

7.  Valence-specific conflict moderation in the dorso-medial PFC and the caudate head in emotional speech.

Authors:  Sonja A Kotz; Reinhard Dengler; Matthias Wittfoth
Journal:  Soc Cogn Affect Neurosci       Date:  2014-02-12       Impact factor: 3.436

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

9.  Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.

Authors:  G Sedvall; P Karlsson; A Lundin; M Anvret; T Suhara; C Halldin; L Farde
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

10.  Cortical dysfunction in patients with Huntington's disease during working memory performance.

Authors:  Robert C Wolf; Nenad Vasic; Carlos Schönfeldt-Lecuona; Daniel Ecker; Georg Bernhard Landwehrmeyer
Journal:  Hum Brain Mapp       Date:  2009-01       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.